HCA Healthcare (NYSE:HCA) PT Lowered to $280.00

HCA Healthcare (NYSE:HCA – Free Report) had its price objective decreased by Stephens from $300.00 to $280.00 in a research report released on Wednesday morning, Benzinga reports. Stephens currently has an overweight rating on the stock. Several other research analysts also recently commented on the company. Royal Bank of Canada restated an outperform rating and […]

Leave a Reply

Your email address will not be published.

Previous post Russian forex reserves growing
Next post General Motors (NYSE:GM) Price Target Cut to $37.00 by Analysts at Barclays